U.S. House · 118th Congress · H.R. 7248

FDA Modernization Act 3.0

To amend the Federal Food, Drug, and Cosmetic Act to establish a process for the qualification of nonclinical testing methods to reduce and replace the use of animals in nonclinical research, improve the predictivity of nonclinical testing methods, and reduce development time for a biological product or other drug, and for other purposes.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
Earl L. "Buddy" CarterR-GA-1
Introduced
February 6, 2024, in the House
Issue areas
Policy area
Health (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (46)

24 Democrats, 22 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these

Signed on later